Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
8.94
-0.08 (-0.89%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Actuate Therapeutics Employees
Actuate Therapeutics had 5 employees as of December 31, 2023.
Employees
5
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$5,763,671
Market Cap
174.61M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nevro | 1,215 |
| Senseonics Holdings | 132 |
| Profound Medical | 131 |
| EUDA Health Holdings | 106 |
| Acumen Pharmaceuticals | 52 |
| Candel Therapeutics | 42 |
| DiaMedica Therapeutics | 19 |
| Atossa Therapeutics | 12 |
ACTU News
- 10 hours ago - Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development - GlobeNewsWire
- 7 weeks ago - Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma - GlobeNewsWire
- 7 weeks ago - Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - U.S. IPO Weekly Recap: WeRide Reschedules While 6 New Filers Join The Pipeline - Seeking Alpha
- 2 months ago - Actuate Therapeutics Announces Closing of Initial Public Offering - GlobeNewsWire
- 2 months ago - Actuate Therapeutics Announces Pricing of Initial Public Offering - GlobeNewsWire
- 3 months ago - U.S. IPO Weekly Recap: August Kicks Off With One Small Pricing - Seeking Alpha
- 3 months ago - U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week - Seeking Alpha